Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Collegium Pharmaceutical Inc
About COLL
Collegium Pharmaceutical, Inc. is a diversified biopharmaceutical company. The Company has developed, licensed, and acquired a portfolio of products for use in the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. Its commercial products include Jornay PM (Jornay), Belbuca, Xtampza ER (Xtampza), Nucynta ER and Nucynta IR (Nucynta Products), and Symproic in the United States. Its Jornay is a central nervous system (CNS) stimulant prescription medicine for the treatment of ADHD. The Belbuca is a buccal film that contains buprenorphine for severe and persistent pain. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone. The Xtampza ER is a pain treatment option designed with abuse deterrent properties. Its portfolio also includes AZSTARYS (serdexmethylphenidate and dexmethylphenidate), a central nervous system (CNS) stimulant prescription medicine used for the treatment of ADHD in people six years of age and older.
Find out what a historical investment in Collegium Pharmaceutical Inc would be worth today using our COLL stock calculator.
Market Capitalisation
$1.09B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
322.89K
High today
$34.46
Low today
$33.45
Open price
$33.83
52-week high
$50.79
52-week low
$28.34
Ready to start your investing journey with Stake?
Open an accountHow do I buy COLL shares in Australia?
Buying COLL shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Collegium Pharmaceutical Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in COLL
What is the ticker symbol of Collegium Pharmaceutical Inc?
The ticker symbol for Collegium Pharmaceutical Inc is COLL.
How much is one share of COLL?
One share of COLL is valued at $34.34 as of 20 May 2026.
What is the market capitalisation of Collegium Pharmaceutical Inc COLL?
As of 20 May 2026 Collegium Pharmaceutical Inc has a market cap of $1.09B.
What is the P/E ratio of COLL?
The Price to Earnings ratio of COLL is 16.51.
What is the Earnings Per Share of COLL?
The Earnings Per Share of COLL is $2.04.
What is the 52-week high for Collegium Pharmaceutical Inc stock?
The Collegium Pharmaceutical Inc 52-week high stock price is $50.79.
What is the 52-week low for Collegium Pharmaceutical Inc stock?
The Collegium Pharmaceutical Inc 52-week low stock price is $28.34.
Can I buy COLL shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy COLL shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in COLL on Stake
- Buy COLL from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of COLL from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
COLL related stocks